|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.50 INR | +2.85% |
|
+5.06% | -3.64% |
| 05-25 | Choksi Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| 05-19 | Choksi Laboratories CFO Resigns, Successor Named; Shares Jump 6% | MT |
Company Valuation: Choksi Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 57.18 | 54.96 | 176.9 | 232.9 | 295.2 | 836.9 |
| Change | - | -3.9% | 221.93% | 31.65% | 26.73% | 183.51% |
| Enterprise Value (EV) 1 | 388.4 | 443.4 | 545.7 | 551 | 597.3 | 1,122 |
| Change | - | 14.15% | 23.09% | 0.97% | 8.4% | 87.9% |
| P/E | -1.47x | -2.11x | 85.5x | 7.26x | 26.7x | 54.9x |
| PBR | 0.28x | 0.31x | 0.99x | 1.1x | 1.33x | 3.55x |
| PEG | - | 0.1x | -1x | 0x | -0.4x | 1.5x |
| Capitalization / Revenue | 0.2x | 0.21x | 0.59x | 0.68x | 0.8x | 2x |
| EV / Revenue | 1.38x | 1.73x | 1.82x | 1.6x | 1.63x | 2.69x |
| EV / EBITDA | 13.6x | 12.6x | 6.62x | 5.73x | 6.19x | 10.5x |
| EV / EBIT | -38.1x | -97x | 15.7x | 11.6x | 13.2x | 23.6x |
| EV / FCF | -3.34x | -11.4x | 43.3x | -412x | 81.2x | 57.8x |
| FCF Yield | -29.9% | -8.81% | 2.31% | -0.24% | 1.23% | 1.73% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -5.58 | -3.744 | 0.2972 | 4.609 | 1.59 | 2.187 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 281.6 | 256.9 | 300.4 | 344.4 | 367 | 417.8 |
| EBITDA 1 | 28.62 | 35.25 | 82.49 | 96.24 | 96.53 | 106.7 |
| EBIT 1 | -10.19 | -4.573 | 34.66 | 47.43 | 45.13 | 47.48 |
| Net income 1 | -38.85 | -26.08 | 2.07 | 32.1 | 11.1 | 15.23 |
| Net Debt 1 | 331.2 | 388.4 | 368.8 | 318.1 | 302.1 | 285.4 |
| Reference price 2 | 8.21 | 7.89 | 25.40 | 33.44 | 42.38 | 120.15 |
| Nbr of stocks (in thousands) | 6,965 | 6,965 | 6,965 | 6,965 | 6,965 | 6,965 |
| Announcement Date | 9/6/20 | 9/4/21 | 9/1/22 | 9/4/23 | 8/26/24 | 8/22/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 8.85M | |
| 24.74x | 2.91x | 12.95x | 3.35% | 23.46B | |
| 45.95x | 6.04x | 22.28x | 0.58% | 19.55B | |
| 19.92x | 2.87x | 11.77x | 1.31% | 3.47B | |
| 11.1x | - | - | 2.95% | 1.85B | |
| -39.09x | 1.34x | 8.61x | -.--% | 1.8B | |
| 24.06x | - | - | 2.12% | 1.73B | |
| Average | 14.45x | 3.29x | 13.90x | 1.72% | 7.41B | |
| Weighted average by Cap. | 29.69x | 4.12x | 16.48x | 2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CHOKSILA6 Stock
- Valuation Choksi Laboratories Limited
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
